Jianfeng Li Selected Research

9- chloro- 9- (4- diethylaminophenyl)- 10- phenylacridan (C 390)

4/2016

Novel compound heterozygous mutations in MYO7A gene associated with autosomal recessive sensorineural hearing loss in a Chinese family.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianfeng Li Research Topics

Disease

65	Neoplasms (Cancer) 01/2022 - 06/2005
19	Glioma (Gliomas) 12/2021 - 01/2007
11	Ototoxicity 11/2020 - 06/2016
11	Hearing Loss (Hearing Impairment) 10/2019 - 11/2011
10	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2002
8	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 04/2008
8	Inflammation (Inflammations) 10/2021 - 01/2013
8	Carcinoma (Carcinomatosis) 01/2021 - 04/2008
6	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 05/2011
6	Congenital Abnormalities (Deformity) 01/2021 - 01/2018
6	Brain Neoplasms (Brain Tumor) 01/2021 - 08/2011
5	Sensorineural Hearing Loss 10/2019 - 01/2016
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 06/2005
5	Lung Neoplasms (Lung Cancer) 04/2012 - 04/2005
4	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 12/2012
4	Facial Paralysis (Facial Palsy) 12/2019 - 04/2012
4	Breast Neoplasms (Breast Cancer) 10/2019 - 03/2015
4	Necrosis 05/2019 - 04/2007
3	Infections 04/2022 - 07/2010
3	Hypertension (High Blood Pressure) 09/2021 - 03/2004
3	Melanoma (Melanoma, Malignant) 06/2019 - 06/2005
3	Erectile Dysfunction 01/2019 - 06/2005
3	Long QT Syndrome 11/2018 - 04/2003
3	Catalepsy 02/2018 - 01/2016
3	Weight Gain 01/2018 - 01/2016
3	Migraine Disorders (Migraine) 11/2017 - 05/2011
3	Metaplasia 01/2016 - 01/2013
3	Sneezing 01/2016 - 01/2013
3	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2012 - 10/2003
3	Stroke (Strokes) 12/2003 - 10/2003
2	Acute Kidney Injury (Acute Renal Failure) 03/2022 - 09/2020
2	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 08/2021 - 06/2008
2	Shock 05/2021 - 03/2019
2	Pain (Aches) 01/2021 - 11/2017
2	Obstructive Sleep Apnea 11/2020 - 10/2019
2	Wounds and Injuries (Trauma) 02/2020 - 12/2011
2	Thymoma (Thymic Carcinoma) 01/2020 - 12/2017
2	Rupture 08/2019 - 11/2018
2	Hemorrhage 07/2019 - 04/2012
2	Disease Progression 06/2019 - 11/2014

Drug/Important Bio-Agent (IBA)

20	Pharmaceutical PreparationsIBA 03/2022 - 06/2012
14	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2007
11	Cisplatin (Platino)FDA LinkGeneric 11/2020 - 01/2017
10	LigandsIBA 01/2022 - 02/2011
9	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2011
7	MicellesIBA 08/2019 - 10/2012
7	Peptides (Polypeptides)IBA 02/2016 - 07/2010
6	EnzymesIBA 12/2021 - 08/2011
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 02/2011
5	Biological ProductsIBA 01/2022 - 12/2007
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2015
5	CytokinesIBA 08/2020 - 04/2008
5	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2018 - 12/2003
5	Dendrimers (Dendrons)IBA 01/2016 - 02/2011
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2021 - 07/2010
4	Long Noncoding RNAIBA 10/2021 - 11/2018
4	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2020 - 10/2007
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 10/2007
4	Small Interfering RNA (siRNA)IBA 11/2015 - 12/2012
4	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 03/2015 - 02/2011
4	Messenger RNA (mRNA)IBA 11/2013 - 06/2005
3	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2019
3	GraphiteIBA 08/2021 - 08/2019
3	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 10/2011
3	HydrogelsIBA 01/2021 - 01/2015
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 07/2010
3	Therapeutic UsesIBA 11/2020 - 04/2008
3	Phosphodiesterase 5 InhibitorsIBA 01/2019 - 06/2005
3	Phencyclidine (Angel Dust)IBA 02/2018 - 01/2016
3	Pattern Recognition ReceptorsIBA 01/2017 - 07/2010
3	Poly(amidoamine)IBA 01/2016 - 02/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 11/2008
3	OvalbuminIBA 01/2016 - 01/2013
3	Immunoglobulin E (IgE)IBA 01/2016 - 01/2013
3	Transferrin Receptors (Transferrin Receptor)IBA 01/2016 - 02/2011
3	Choline (Choline Chloride)IBA 09/2015 - 01/2013
3	Contrast MediaIBA 01/2013 - 04/2011
3	Peroxynitrous Acid (Peroxynitrite)IBA 11/2011 - 10/2003
2	AlginatesIBA 03/2022 - 09/2020
2	Circular RNAIBA 01/2022 - 01/2021
2	Aldehyde DehydrogenaseIBA 12/2021 - 05/2013
2	Competitive Endogenous RNAIBA 10/2021 - 11/2020
2	CaspasesIBA 01/2021 - 01/2015
2	RNA (Ribonucleic Acid)IBA 01/2021 - 03/2013
2	salicylhydroxamic acid (SHAM)IBA 11/2020 - 05/2011
2	LipopolysaccharidesIBA 08/2020 - 09/2015
2	Surface-Active Agents (Surfactants)IBA 08/2019 - 09/2015
2	allicinIBA 01/2019 - 01/2017

Therapy/Procedure

28	Therapeutics 01/2022 - 02/2011
14	Drug Therapy (Chemotherapy) 01/2021 - 03/2010
6	External Fixators 01/2021 - 01/2018
4	Sympathectomy (Sympathectomies) 11/2018 - 04/2003
4	Thoracotomy 01/2017 - 11/2002
3	Intravenous Administration 01/2015 - 03/2011
2	Microspheres (Microsphere) 03/2022 - 09/2020
2	Fecal Microbiota Transplantation 10/2021 - 01/2021
2	Bioelectric Energy Sources 05/2021 - 03/2019
2	Osteotomy 12/2020 - 03/2020
2	Thymectomy 01/2020 - 12/2017
2	Length of Stay 07/2019 - 08/2018